Filings

2 documents · 7 matches

1. LABT Lakewood-Amedex Biotherapeutics Inc. 10-Q 2026-08-14

   Item 4. Controls and Procedures.

   material weaknesses described above are the same material weaknesses previously disclosed in the Company’s Registration Statement on Form S-1 and Quarterly
   4 matches in this document Show context Copy citation

2. LABT Lakewood-Amedex Biotherapeutics Inc. 10-Q 2026-05-22

   Item 4. Controls and Procedures.

   material weaknesses in its internal controls over financial reporting, The material weaknesses identified include the following: (i) the Company’s documentation
   3 matches in this document Show context Copy citation